サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1363199

セルカウンティングの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年

Cell Counting Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables & Accessories), By Application (Complete Blood Count, Stem Cell Research), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
セルカウンティングの市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2023年～2030年
出版日: 2023年09月25日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

セルカウンティング市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のセルカウンティング市場規模は、2023年から2030年にかけてCAGR 8.2％で拡大し、2030年には154億6,000万米ドルに達する見込みです。

がん、HIV、アルツハイマーなどの慢性疾患の有病率の上昇が、この業界の成長促進要因となっています。これらの疾患の有病率の増加は、臨床研究活動を急増させ、その結果、セルカウンティング装置と消耗品の需要を促進しています。セルカウンティングが重要な役割を果たす細胞治療薬の開発を促進する政府の取り組みも、市場の成長見通しを拡大しています。

研究開発を促進するための様々な官民団体との研究機関の共同研究の増加が成長を大きく後押ししています。高品質の標準を確保し、正確な結果の生成を促進するために、公的機関や民間の研究所に対して提案されるガイドラインや推奨事項の数が増加していることが、今後数年間における機器の採用を改善する可能性が高いです。例えば、2021年5月、国際幹細胞学会は細胞ベースの治療・研究開発のためのガイドラインを更新しました。提案されたガイドラインは、研究開発の全段階に焦点を当て、前臨床研究の質を向上させるものです。

これらの装置における技術的進歩もまた、市場の成長見通しを広げています。分化セルカウンティングにおける有望な技術進歩の一つは、芽球の認識、免疫小板計数、芽球の検出、網状赤血球分画、幹セルカウンティングをより高い精度で行えるようになったことです。CD4+Tセルカウンティング技術の出現は、免疫反応の指標として非常に有用であることが証明され、抗レトロウイルス療法（ARV）の成否を評価するために採用されています。CD4＋T細胞およびCD8＋T細胞の計数を行う専用のサイトメーターが市場にあり、例えばBecton Dickinson社のFACSCountはTセルカウンティング技術に基づいています。

COVID-19のパンデミックは、業界の成長にプラスの影響を与えると予想されています。入院中のCOVID-19患者のWBC数は、患者の死亡と有意な相関関係があります。COVID-19の治療では、白血球数が高ければ高いほど、さらに注意を払う必要があります。COVID-19に罹患した患者における細胞数の重要性の高まりは、パンデミック時の業界の成長を増大させました。

強化された情報科学ソリューションと光学顕微鏡や蛍光顕微鏡のような改良された画像分析機器の市場開拓が、この市場の成長見通しに拍車をかけています。これらの機器は、新興経済諸国に多く見られる低サンプルスループットの検査室やリソースの限られた環境でますます採用されるようになっており、それによって業界の成長余地が広がっています。

一方、熟練した専門家の数が限られていることが、市場の成長を抑制する重大な要因となっています。熟練プロフェッショナルの不足は、トレーニング施設の不足とトレーニングコストの高さに起因しています。このシナリオを改善するために、業界各社はこれらの企業が開発したソフトウェアのトレーニングプログラムの作成に参加し、ヘルスケア専門家や研究者にセルカウンティングソフトウェアの操作を奨励することが求められています。さらに、これらのソフトウェアツールが標準化されていないことも、ソフトウェアごとにユーザーインターフェースが異なるため、研究者やヘルスケア専門家を制限する上で重要な役割を果たしています。

セルカウンティング市場レポートハイライト

  • 製品別では、消耗品・付属品セグメントが2022年に54.14%の最大収益シェアを占め、予測期間中に8.4%のCAGRで最速成長すると予測されています。
  • 消耗品・付属品セグメントでは、試薬が2022年に56.3%の最大収益シェアを占めました。この大きな収益シェアは、分光光度法、フローサイトメトリー、自動セルカウンティングの際に使用するこれらの製品を繰り返し購入することに起因しています。
  • マイクロプレートサブセグメントは、予測期間中に最も速いCAGRで拡大する見込みです。マイクロプレートは通常、非常に低濃度のサンプルの分析に使用されます。マイクロプレートの消費が増加しているのは、汚染を防ぐために新しいサンプルを分析する際に新しいプレートを繰り返し使用する必要があるためです。
  • 機器分野では、自動セルカウンターが予測期間中に指数関数的な成長を遂げると予測されています。検査時間の短縮、エラー発生の低減、オペレーター間のばらつきといった利点により、自動化カウンターの需要がさらに高まると予想されます。
  • 用途別では、完全血球計数分野が2022年に59.1%の最大収益シェアを占めました。この大きな収益シェアは、血液疾患の発生率の増加に起因しています。
  • 最終用途分野では、様々な毒性学的研究の研究開発促進に焦点を当てた政府イニシアチブの増加により、研究・学術機関が2022年に39.6％の最大収益シェアを占めました。
  • 製薬企業およびバイオテクノロジー企業は、予測期間中にCAGR 9.0%の最速成長を遂げると予測されています。
  • 北米は、生物医学およびがん研究への注目が高まっていることから、37.6％以上の最大収益シェアを占めています。
  • アジア太平洋地域は、臨床研究機関やバイオ製薬企業が多く存在することから、予測期間中に10.3％のCAGRで急成長すると予測されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 セルカウンティング市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 業界のバリューチェーン分析
    • 償還の枠組み
  • 市場力学
    • 市場促進要因の分析
    • 市場抑制要因分析
  • セルカウンティング市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 セルカウンティング市場：製品タイプ別推定・動向分析

  • セルカウンティング市場：重要なポイント
  • セルカウンティング市場：動向と市場シェア分析、2022年と2030年
  • 機器
  • 消耗品と付属品

第5章 セルカウンティング市場：用途別推定・動向分析

  • セルカウンティング市場：重要なポイント
  • セルカウンティング市場：動向と市場シェア分析、2022年と2030年
  • 全血球計算
  • 幹細胞調査
  • 細胞ベース治療
  • バイオプロセシング
  • 毒物学
  • その他

第6章 セルカウンティング市場：地域別推定・動向分析

  • 地域別の見通し
  • 地域別のセルカウンティング市場：主要なマーケットプレース要点
  • 北米
    • 市場推計・予測、2018～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • ThermoFisher Scientific, Inc
    • Merck KGaA
    • Agilent Technologies
    • PerkinElmer, Inc
    • BD
    • Danaher
    • Bio-Rad Laboratories, Inc
    • BioTek Instruments, Inc
    • GE Healthcare
    • DeNovix Inc
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 23 France cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 24 France cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Sweden cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Norway cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 44 China cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 45 China cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 46 China cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 49 Japan cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 51 India cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 52 India cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Thailand cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 54 Thailand cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 55 Thailand cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Korea cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Latin America cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 60 Latin America cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 61 Latin America cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 63 Brazil cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 64 Brazil cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 65 Brazil cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Mexico cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 67 Mexico cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 68 Mexico cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Argentina cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 70 Argentina cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 71 Argentina cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Middle East and Africa cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 73 Middle East and Africa cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 74 Middle East and Africa cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa cell counting market, by region, 2018 - 2030 (USD Million)
  • Table 76 South Africa cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 77 South Africa cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 78 South Africa cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Saudi Arabia cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 80 Saudi Arabia cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 UAE cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 83 UAE cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 84 UAE cell counting market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Kuwait cell counting market, by product, 2018 - 2030 (USD Million)
  • Table 86 Kuwait cell counting market, by application, 2018 - 2030 (USD Million)
  • Table 87 Kuwait cell counting market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Cell counting: Market outlook
  • Fig. 9 Cell counting: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Cell counting market driver impact
  • Fig. 15 Cell counting market restraint impact
  • Fig. 16 Cell counting market strategic initiatives analysis
  • Fig. 17 Cell counting market: Product type movement analysis
  • Fig. 18 Cell counting market: Product type outlook and key takeaways
  • Fig. 19 Instruments market estimates and forecasts, 2018 - 2030
  • Fig. 20 Consumables & accessories market estimates and forecasts, 2018 - 2030
  • Fig. 21 Cell counting market: Application movement analysis
  • Fig. 22 Cell counting market: Application outlook and key takeaways
  • Fig. 23 Complete blood count market estimates and forecasts, 2018 - 2030
  • Fig. 24 Stem cell research market estimates and forecasts, 2018 - 2030
  • Fig. 25 Cell-based therapeutics market estimates and forecasts, 2018 - 2030
  • Fig. 26 Bioprocessing market estimates and forecasts, 2018 - 2030
  • Fig. 27 Toxicology market estimates and forecasts, 2018 - 2030
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030
  • Fig. 29 Cell counting market: End-use movement analysis
  • Fig. 30 Cell counting market: End-use outlook and key takeaways
  • Fig. 31 Hospitals & diagnostic laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 32 Research & academic Institutes market estimates and forecasts, 2018 - 2030
  • Fig. 33 Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 - 2030
  • Fig. 34 Others market estimates and forecasts, 2018 - 2030
  • Fig. 35 Global cell counting market: Regional movement analysis
  • Fig. 36 Global cell counting market: Regional outlook and key takeaways
  • Fig. 37 North America market estimates and forecasts, 2018 - 2030
  • Fig. 38 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 39 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 40 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 41 U.K. market estimates and forecasts, 2018 - 2030
  • Fig. 42 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 43 France market estimates and forecasts, 2018 - 2030
  • Fig. 44 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 45 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 46 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 47 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 48 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 49 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 50 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 51 China market estimates and forecasts, 2018 - 2030
  • Fig. 52 India market estimates and forecasts, 2018 - 2030
  • Fig. 53 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 54 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 55 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 56 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 57 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 58 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 59 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 60 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 61 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 62 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 63 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 64 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-1-68038-592-2

Cell Counting Market Growth & Trends:

The global cell counting market size is expected to reach USD 15.46 billion by 2030, expanding at a CAGR of 8.2% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Rising prevalence of chronic diseases such as cancer, HIV, and Alzheimer's is the high impact rendering growth driver of the industry. Increasing prevalence of these diseases has surged clinical research activities, consequently propelling the demand for cell counting instruments and consumables. Government initiatives working to promote the development of cell therapeutics, wherein cell counting plays an imperative role, are also expanding growth prospects for the market.

An increase in the number of collaborations of research institutes with various public and private entities to promote R&D has provided a significant boost to growth. Growing number of proposed guidelines and recommendations for public and private laboratories to ensure high-quality standards and facilitate the generation of accurate results are likely to improve the adoption of instruments over the coming years. For instance, in May 2021, the International Society for Stem Cell Research updated guidelines for the development of cell-based therapy and research. The proposed guidelines focus on all stages of R&D and improve the quality of preclinical studies.

Technological advancements in these devices are also broadening growth prospects of the market. One of the promising technological advancements in differential cell counting is the ability to recognize blasts, immunoplatelet counting, detection of blasts, and reticulocyte fractions and stem cell counting with greater accuracy. The advent of CD4+ T-cell counting technology has proven to be very useful as an indicator of immune responses and has been adopted to evaluate the success or failure of Anti-retroviral Therapy (ARV). Dedicated cytometers are present in the market to perform CD4+ and CD8+ T-cell enumeration, such as the FACSCount by Becton Dickinson is based on T-cell counting technology.

The COVID-19 pandemic is anticipated to positively impact industry growth. WBC count of the COVID-19 patient during admission is significantly correlated with the death of patients. A higher level of white blood count should be given further care in the COVID-19 treatment. The growing importance of cell count in patients suffering from COVID-19 has augmented the growth of the industry during the pandemic.

The development of enhanced informatics solutions and improved image analysis instruments such as optical or fluorescence microscopes have fueled the growth prospects of this market. These instruments are being increasingly adopted in low sample throughput laboratories and settings with limited resources, which is highly prevalent in developing economies, thereby broadening the scope for growth of the industry.

On the other hand, limited availability of skilled professionals is the critical growth-restraining factor of the market. The lack of skilled professionals can be attributed to a lack of training facilities and high training costs. In order to improve this scenario, industry players are required to participate in the generation of training programs for software developed by these companies and encourage healthcare professionals and researchers to operate cell counting software. Moreover, the lack of standardization of these software tools also plays a key role in restricting researchers and healthcare professionals as every software differ in user interface.

Cell Counting Market Report Highlights:

  • By product, consumables and accessories segment accounted for the largest revenue share of 54.14% in 2022 and is expected to grow at the fastest CAGR of 8.4% over the forecast period
  • In the consumables and accessories segment, reagents held the largest revenue share of 56.3% in 2022. The large revenue share is attributed to the repeat purchase of these products for use during spectrophotometry, flow cytometry, and automated cell counting
  • The microplates sub-segment is poised to expand at the fastest CAGR during the forecast period. Microplates are usually used for analyzing very low concentration samples. The increased consumption of these plates is attributed to the repeated need to use fresh plates for analyzing a new sample to prevent contamination
  • In the instruments segment, automated cell counters are anticipated to grow at an exponential rate during the forecast period. Benefits such as short testing time, reduced error occurrence, and inter-operator variability are expected to further increase the demand for automated counters
  • By application, the complete blood count segment held the largest revenue share of 59.1% in 2022. The large revenue share can be attributed to increasing incidence of blood disorders
  • In the end-use segment, research and academic institutes accounted for the largest revenue share of 39.6% in2022 owing to growing number of government initiatives focused on promoting R&D in various toxicology studies
  • Pharmaceutical and biotechnology companies are anticipated to grow at the fastest CAGR of 9.0% during the forecast period
  • North America held the largest revenue share of over 37.6% owing to the increasing focus on biomedical and cancer research
  • Asia Pacific is expected to grow at the fastest CAGR of 10.3% over the forecast period owing to the large presence of clinical research organizations and biopharmaceutical companies in this region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End Use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cell Counting Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
  • 3.5. Cell Counting Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic Landscape

Chapter 4. Cell Counting Market: Product Type Estimates & Trend Analysis

  • 4.1. Cell Counting Market: Key Takeaways
  • 4.2. Cell Counting Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Instruments
    • 4.3.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Spectrophotometers
      • 4.3.2.1. Spectrophotometers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Flow cytometers
      • 4.3.3.1. Flow cytometers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.4. Hemocytometers
      • 4.3.4.1. Hemocytometers market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.5. Automated cell counters
      • 4.3.5.1. Automated cell counters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.6. Microscopes
      • 4.3.6.1. Microscopes market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Consumable & Accessories
      • 4.4.1.1. Consumable & Accessories market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Reagents
      • 4.4.2.1. Reagents market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Microplates
      • 4.4.3.1. Microplates market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Others
      • 4.4.4.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cell Counting Market: Application Estimates & Trend Analysis

  • 5.1. Cell Counting Market: Key Takeaways
  • 5.2. Cell Counting Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Complete Blood Count
    • 5.3.1. Complete blood count market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Stem Cell Research
    • 5.4.1. Stem cell research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Cell-Based Therapeutics
    • 5.5.1. Cell-based therapeutics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Bioprocessing
    • 5.6.1. Bioprocessing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Toxicology
    • 5.7.1. Toxicology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cell Counting Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Cell Counting Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. U.K.
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. ThermoFisher Scientific, Inc
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Merck KGaA
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Agilent Technologies
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. PerkinElmer, Inc
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. BD
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Danaher
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Bio-Rad Laboratories, Inc
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. BioTek Instruments, Inc
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. GE Healthcare
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. DeNovix Inc
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives